ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R ...

You can minimize the risk of films and shows being spoiled for you by muting comments, conversations, and keywords on various ...

Ways to Lower Your Diabetes Risk Diabetes is a growing concern worldwide, and understanding how to lower your risk is crucial ...

SEC asks Abbvie to conduct Phase III study on subcutaneous drug for Parkinson's disease: Our Bureau, New Delhi Friday, July 3, 2026, 08:00 Hrs [IST] A Subject Expert Committee (SE ...

Deltarune Chapter 5 is subtitled Festival Day. It is the first entry in the series to offer more than one real ending. Every chapter before it funneled players into the exact same closing cutscene.

After traversing the vibrant gardens of a new Dark World, Kris, Susie, and Ralsei have gained an item allowing them to traverse the world in new ways, leading up to the Garden Cliffs overlooking the ...

She specifically discusses the available treatment options in frontline EGFR mutation–positive advanced non–small cell lung cancer and what particular clinical and lifestyle benefits are provided by ...

Shares of Viking Therapeutics (NASDAQ: VKTX) have climbed by 27% over the past month. The drugmaker is a serious candidate to make waves in the large and growing anti-obesity drug market. With several ...

On June 29, at the 12 th Congress of the European Academy of Neurology (EAN) 2026, NeuroDerm presented post hoc analysis from ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it will report financial ...

Misako Nagasaka, MD, PhD, describes the tolerability results with subcutaneous (SC) amivantamab plus lazertinib in patients with treatment-naïve, EGFR-mutated advanced non–small cell lung cancer from ...

Thousands of patients with multiple sclerosis face the prospect of losing publicly funded access to vital medicines as ...